BENAZEPRIL, AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR, ALLEVIATES RENAL INJURY IN SPONTANEOUSLY HYPERTENSIVE RATS BY INHIBITING ADVANCED GLYCATION END-PRODUCT-MEDIATED PATHWAYS-Reference-Cited by-同舟云学术

BENAZEPRIL, AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR, ALLEVIATES RENAL INJURY IN SPONTANEOUSLY HYPERTENSIVE RATS BY INHIBITING ADVANCED GLYCATION END-PRODUCT-MEDIATED PATHWAYS

Published:2009-03 Issue:3 Volume:36 Page:287-296
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:

Author:

Liu Xue-Ping,Pang Yue-Jiu,Zhu Wei-Wei,Zhao Ting-Ting,Zheng Min,Wang Yi-Bing,Sun Zhi-Jian,Sun Siao-Jing

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1681.2008.05078.x/fullpdf

Reference44 articles.

1. Mechanisms of diabetic vasculopathy: An overview;Cooper;Am. J. Hypertens,2001

2. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins;Neeper;J. Biol. Chem,1992

3. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy;Bolton;Am. J. Nephrol,2004

4. The AGE-RAGE system and diabetic nephropathy;Sakurai;J. Am. Soc. Nephrol,2003

5. Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure;Aronson;Med. Hypotheses,2002

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19—The Role of RAGE-RAS Crosstalk;Biomolecules;2021-06-12

2. Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways;Free Radical Biology and Medicine;2020-09

3. The protective effect of losartan against sorafenib induced cardiotoxicity: Ex-vivo isolated heart and metabolites profiling studies in rat;European Journal of Pharmacology;2020-09

4. Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes;The Journal of Clinical Endocrinology & Metabolism;2019-03-14

5. Inhibition of RAGE Axis Signaling: A Pharmacological Challenge;Current Drug Targets;2019-01-25